At BluSense, we believe that one creates value as long as one attributes value to the life of others. By creating accurate and fast diagnostics tests for multiple parameters, we help people live longer and healthier lives.
Bridging Copenhagen and Taipei
By combining modern Scandinavian bioengineering and medical device design with first-rate Taiwanese hardware, software and manufacturing engineering, BluSense has created a breakthrough diagnostics reader device.
A life-changing influence on people’s lives
We create innovative, life-changing medical devices that provide patients and healthcare professionals with quick and accurate results.
Meet our team
Leif Helth Jensen
Chairman of the Board
Experienced scientist and business man
Co-author on more than 30 scientific peer reviewed articles and 20 patent families
Co-founder of NeuroSearch (IPO in 1996)
Co-founder and CEO of Cureon (sold to Roche)
Co-founder and Board member of Zealand Pharma (IPO in 2010)
Seed investor and Board member of GenMab (IPO in 2004)
Co-founder and CEO of Glycom (sold to DSM in 2020)